A Middle-aged Caucasian Male with Hypogonadism, Returning for Follow-Up
Hypogonadism affects 2-4 million men in the United States, but because of the nonspecific nature of the symptoms, most men do not complain, and the condition remains underdiagnosed. Furthermore, prevailing concepts of 'maleness' and sexuality, and lack of awareness among primary care physicians, contribute to disregarding the importance of male hypogonadism, even though it is associated with a reduced quality of life. As a result, many male patients with hypogonadism are untreated. This interactive case follows up on a 52-year-old male patient previously identified with multiple features consistent with hypogonadism and who initiated treatment with transdermal testosterone gel four weeks earlier.

Upon completion, participants should be able to:
• Order appropriate laboratory testing to make a diagnosis and differentiate between primary and secondary hypogonadism.
• Identify appropriate management strategies, utilizing traditional testosterone replacement therapies and newer modalities such as transdermal patches, gels and buccal tablets.
• Monitor ongoing therapy more confidently to optimize outcomes and minimize morbidity.

» Go to this activity

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.